Eisai (Japan)

Eisai (Japan)

Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Eisai (Japan), Japan, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

46%


Total
Publications

4.6K


Total Open
Publications

2.1K


Total
Citations

151K


Open Access
Percentage

46%


Total
Publications

4.6K


Total Open
Publications

2.1K


Total
Citations

151K

Wikipedia

Website

download

Breakdown

23% 19% 3% 55%

Publisher Open

23%

Both

19%

Other Platform Open

3%

Closed

55%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

050100150200250300350Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

32%OA Journal

OA Journal 32%

611

Hybrid 28%

525

No Guarantees 40%

764

Other Platform Open

Domain 83%

864

Institution 16%

166

Other Internet 13%

131

Public 2%

22

Preprint 1%

7

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
867
DOI
Other Internet
127
Europe PMC
Domain
39
DANS - Data Archiving and Networked Services
Institution
22
Figshare
Public
20
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
13
Yonsei University Medical Library - YUHSpace
Institution
12
University of Melbourne - Minerva Access
Institution
8
Alma Mater Studiorum Università di Bologna - Archivio istituzionale della ricerca
Institution
8
Université Libre de Bruxelles - Dépôt institutionnel de l'Université libre de Bruxelles
Institution
6
1 / 10

Data updated 18 August 2025

Share

Share

Share